Assessment of Stimulant Use and Cardiovascular Event Risks Among Older Adults

Authors:

Abstract
Stimulants act on the central nervous system (CNS) to increase alertness, attention, and energy.1,2 Although stimulants are most commonly used among children and youth for the treatment of attention-deficit/hyperactivity disorder (ADHD),3,4 an increase in stimulant use among older adults in recent years has been observed.5 Off-label uses of stimulants among older adults include the treatment of depression, poststroke recovery, motor function, and fatigue.2,6-13 This increase in use has been reported despite concerns regarding cardiovascular (CV) safety.14-19 Because of their effects on monoamine transmission, stimulants increase resting heart rate and systolic blood pressure. A meta-analysis of 10 randomized clinical trials reported that stimulants were associated with an increase in heart rate of 5.7 beats per minute (bpm) and in systolic blood pressure of 2.0 mm Hg.14 Furthermore, the use of methylphenidate was associated with a 4-fold increase in the odds of developing prehypertension among younger adults who were previously normotensive, and use of this stimulant has been associated with increased platelet aggregation.20-22

This publication has 50 references indexed in Scilit: